CONSORT: Confidential Social Network Referrals for HIV Testing

Sponsor
University of South Carolina (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05967208
Collaborator
Duke University (Other), Kilimanjaro Christian Medical Centre, Tanzania (Other)
600
2
23

Study Details

Study Description

Brief Summary

Despite worldwide efforts to promote HIV testing, rates of testing remain low. The purpose of this study is to evaluate the acceptability, efficacy, and cost-effectiveness of confidential SMS-based social network referrals for HIV testing as a means of reaching high-risk individuals and prompting them to test for HIV. To accomplish this purpose, the study has 5 specific aims:

Aim 1 will conduct qualitative, formative work to identify desirable provider- and client-side characteristics of a confidential SMS-based HIV testing referral system.

Aim 2 will adapt an existing mHealth system (mParis) to add CONSORT functionality.

Aim 3 will pilot-test the CONSORT system to collect preliminary data on the system's acceptability, performance, and potential efficacy.

Aim 4 will evaluate the acceptability and efficacy of CONSORT in a randomized controlled trial.

Aim 5 will evaluate the incremental cost-effectiveness of CONSORT vs. other referral options.

If CONSORT is shown to be acceptable, effective, and cost-effective, such mobile-phone supported, chain-referral methods could greatly improve the cost-effectiveness of HIV testing efforts.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CONSORT referrals
  • Behavioral: Card referrals
N/A

Detailed Description

No additional detail available

Study Design

Study Type:
Interventional
Anticipated Enrollment :
600 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Confidential Social Network Referrals for HIV Testing
Anticipated Study Start Date :
May 1, 2025
Anticipated Primary Completion Date :
Oct 1, 2026
Anticipated Study Completion Date :
Apr 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: CONSORT referrals + Card referrals

Intervention arm

Behavioral: CONSORT referrals
Participants will be offered SMS-based confidential social network referrals for HIV testing ("CONSORT referrals") to extend to any of their social and sexual network contacts.

Behavioral: Card referrals
Participants will be offered physical invitation cards ("card referrals") to extend to any of their social and sexual network contacts.

Active Comparator: Card referrals alone

Control arm

Behavioral: Card referrals
Participants will be offered physical invitation cards ("card referrals") to extend to any of their social and sexual network contacts.

Outcome Measures

Primary Outcome Measures

  1. Uptake of HIV testing [Within 30 days of the time of the testing offer]

    The number of referred clients presenting for HIV testing at participating study sites within 30 days of the testing offer, per 100 index clients.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • at least 18 years old

  • live, work, or regularly receive care in Moshi, Tanzania

  • literate

Exclusion criteria:
  • under age 18 years

  • does not live, work, or regularly receive care in Moshi, Tanzania

  • illiterate

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of South Carolina
  • Duke University
  • Kilimanjaro Christian Medical Centre, Tanzania

Investigators

  • Principal Investigator: Jan Ostermann, PhD, University of South Carolina
  • Principal Investigator: Nathan Thielman, MD, Duke University
  • Principal Investigator: Bernard Njau, PhD, Kilimanjaro Christian Medical Centre, Tanzania

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Jan Ostermann, Associate Professor, University of South Carolina
ClinicalTrials.gov Identifier:
NCT05967208
Other Study ID Numbers:
  • Pro00120208
First Posted:
Aug 1, 2023
Last Update Posted:
Aug 1, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Aug 1, 2023